Blood Purification in Severe and Critical COVID-19 Patients: A Case Series of 5 Patients
Objective: The ongoing coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to a worldwide pandemic. Currently, supportive care measures remain the standard of care for severe and critical COVID-19 patients, such as ventilation oxygen...
Guardado en:
Autores principales: | Hongjun Chen, Leisheng Zhang, Wei Zhang, Lili Liu, Zhihua Dai, Miao Chen, Donghang Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ad327d568bbd4dfcbe4f6275b2091a05 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)
por: Seyed MohammadReza Hashemian, et al.
Publicado: (2021) -
Expert recommendations on blood purification treatment protocol for patients with severe COVID-19
por: Xiang-Hong Yang, et al.
Publicado: (2020) -
Numerical Investigation on the Electrical Performance Optimization of a Tubular Thermoelectric Generator for Waste Heat Recovery
por: Chen Leisheng, et al.
Publicado: (2021) -
Clinical and laboratory variables associated with quality of Ufe in Brazilian haemodialysis patients: a single-centre study
por: Santos,Paulo Roberto, et al.
Publicado: (2008) -
Extracorporeal Cytokine Removal in Critically Ill COVID-19 Patients: A Case Series
por: Marcell Virág, et al.
Publicado: (2021)